Iradimed Revenue Growth Rates (IRMD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Iradimed Corporation  (NASDAQ: IRMD)
 

IRMD's Revenue Growth by Quarter and Year

Iradimed's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IRMD Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 20.47
1st Quarter March 21.98
FY 42.45

IRMDs Annual Revenue
Iradimed's Revenue in the fiscal year 2025 $ 83.81 millions
Iradimed's Revenue in the fiscal year 2024 $ 73.24 millions
Iradimed's Revenue in the fiscal year 2023 $ 65.56 millions
Iradimed's Revenue in the fiscal year 2022 $ 53.30 millions
Iradimed's Revenue in the fiscal year 2021 $ 41.81 millions




IRMD Revenue second quarter 2026 Y/Y Growth Comment
Iradimed Corporation reported Revenue growth of 0.27% year on year in the second quarter 2026, to $ 20.47 millions, this is lower than Iradimed Corporation's recent average Revenue increase of 19.91%.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 130 other companies have achieved higher Revenue growth. While Iradimed Corporation' s Revenue increase of 0.27% ranks overall at the positon no. 2752 in the second quarter 2026.


IRMD Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 17.02 % 11.12 % 17.43 %
3rd Quarter September - 15.66 % 11.09 % 23.04 %
2nd Quarter June 0.27 % 13.83 % 11.16 % 26.81 %
1st Quarter March 12.66 % 10.85 % 13.7 % 25.75 %
FY   - 14.42 % 11.73 % -

Financial Statements
Iradimed's second quarter 2026 Revenue $ 20.47 millions IRMD's Income Statement
Iradimed's second quarter 2025 Revenue $ 20.41 millions Quarterly IRMD's Income Statement


IRMD Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 7.03 % 5.78 % 5.76 %
3rd Quarter September - 3.87 % 2.23 % 2.29 %
2nd Quarter June -6.89 % 4.61 % 1.87 % 4.2 %
1st Quarter March -3.13 % 0.62 % 0.86 % 4.17 %
FY (Year on Year)   - 14.42 % 11.73 % -


Back to IRMD Growth rate Comparisons >> Back to IRMD Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #388
Overall #2752

Revenue Y/Y Growth Statistics
High Average Low
114.95 % 19.91 % -44.02 %
(Mar 31 2022)   (Sep 30 2017)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #131
Healthcare Sector #388
Overall #2752
Revenue Y/Y Growth Statistics
High Average Low
114.95 % 19.91 % -44.02 %
(Mar 31 2022)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Iradimed's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
145.4 % 4.71 % -41.54 %
(Dec 31 2013)  


IRMD's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Iradimed Corporation disclosed decline in Revenue from the first quarter by -6.89% to $ 20.47 millions, from $ 21.98 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 99 other companies have achieved higher Revenue quarter on quarter growth. While Iradimed's Revenue growth quarter on quarter, overall rank is 2613.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #100
Healthcare Sector #325
Overall #2613
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #100
Healthcare Sector #325
Overall #2613
Revenue Q/Q Growth Statistics
High Average Low
145.4 % 4.71 % -41.54 %
(Dec 31 2013)  


IRMD's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2026 Iradimed Corporation disclosed decline in Revenue from the first quarter by -6.89% to $ 20.47 millions, from $ 21.98 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2026 Revenue, this plainly could not be substantial to rescue Medical Equipment & Supplies's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 99 other companies have achieved higher Revenue quarter on quarter growth. While Iradimed's Revenue growth quarter on quarter, overall rank is 2613.


Iradimed's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 86.34 $ 86.28 $ 83.81 $ 80.51 $ 77.64
Y / Y Revenue Growth (TTM) 11.21 % 14.81 % 14.43 % 12.91 % 11.73 %
Year on Year Revenue Growth Overall Ranking # 1297 # 625 # 540 # 480 # 106
Seqeuential Revenue Change (TTM) 0.07 % 2.95 % 4.1 % 3.7 % 3.3 %
Seq. Revenue Growth (TTM) Overall Ranking # 2200 # 1490 # 1373 # 1330 # 500


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Iradimed's cumulative twelve months Revenue were $ 86 millions, company would post below average annual Revenue growth of 3.3% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Iradimed's Revenue growth from the 21.98% growth in Mar 31 2026.

In the Healthcare sector 229 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 625 to 1297.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 230
Overall # 1297

Revenue TTM Y/Y Growth Statistics
High Average Low
39.17 %
 11.8 %
-36.65 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 318
S&P 500 # 2200
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Iradimed's cumulative twelve months Revenue were $ 86 millions, company would post below average annual Revenue growth of -36.65% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Iradimed's Revenue growth from the 21.98% growth in Mar 31 2026.

In the Healthcare sector 229 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 625 to 1297.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 230
Overall # 1297

Revenue TTM Y/Y Growth Statistics
High Average Low
39.17 %
11.8 %
-36.65 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 318
S&P 500 # 2200




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IRMD's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decline for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Conmed Corporation0.33%$ 0.334 millions
Zoetis Inc 0.33%$ 0.325 millions
Iradimed Corporation0.28%$ 0.277 millions


About Iradimed Revenue Growth Rates (IRMD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Iradimed Corp (CIK 1325618).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-051402
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Iradimed Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.